CAMBRIDGE-Moderna announced Health Canada has approved mRESVIA™ (Respiratory Syncy-al Virus mRNA vaccine) for ac-ve immuniza-on for the preven-on of lower respiratory tract disease caused by respiratory syncy-al virus (RSV) in adults 60 years of age and older.1 “This approval is an example of how our mRNA platform can help address significant public health challenges like RSV,” said Stéphane Bancel, Chief …
LITFULO Receives Health Canada Approval
KIRKLAND, QC, December 4, 2023 – Today, Pfizer Canada announced that Health Canada has granted a Notice of Compliance (NOC) for LITFULO™ (ritlecitinib). A once-daily oral treatment, LITFULO is the first and only treatment approved by Health Canada for individuals 12 years of age and older with severe alopecia areata.[i] Approximately two per cent of the global population are affected …